Pyxis Oncology, Inc. — All Filings
318 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
144/A
3
4
424B2
424B3
424B4
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0001193125-26-124388 | Mar 25, 2026 | Mar 24, 2026 |
| 4 | 4 | 0001193125-26-124380 | Mar 25, 2026 | Mar 24, 2026 |
| 4 | 4 | 0001193125-26-124348 | Mar 25, 2026 | Mar 24, 2026 |
| 4 | 4 | 0001193125-26-124342 | Mar 25, 2026 | Mar 24, 2026 |
| 4 | 4 | 0001193125-26-124333 | Mar 25, 2026 | Mar 24, 2026 |
| 4 | 4 | 0001193125-26-124325 | Mar 25, 2026 | Mar 24, 2026 |
| 4 | 4 | 0001193125-26-124319 | Mar 25, 2026 | Mar 24, 2026 |
| 4 | 4 | 0001193125-26-124313 | Mar 25, 2026 | Mar 24, 2026 |
| 4 | FORM 4 | 0000905148-26-001434 | Mar 25, 2026 | Apr 14, 2025 |
| S-8 | S-8 | 0001193125-26-119700 | Mar 23, 2026 | — |
| 10-K | 10-K | 0001193125-26-118532 | Mar 23, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-118525 | Mar 23, 2026 | — |
| SCHEDULE 13G/A | — | 0001390202-26-000002 | Feb 9, 2026 | — |
| 8-K | 8-K | 0001193125-26-041169 | Feb 6, 2026 | — |
| 4 | 4 | 0001193125-26-039951 | Feb 5, 2026 | Feb 3, 2026 |
| 8-K | 8-K | 0001193125-25-323704 | Dec 18, 2025 | — |
| EFFECT | — | 9999999995-25-003615 | Dec 9, 2025 | — |
| S-3 | FORM S-3 | 0001437749-25-036389 | Nov 26, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-261696 | Nov 3, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-261689 | Nov 3, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-099264 | Oct 14, 2025 | — |
| SCHEDULE 13G | — | 0000919574-25-005781 | Sep 23, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-108906 | Aug 14, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-108898 | Aug 14, 2025 | — |
| 8-K | 8-K | 0000950170-25-101618 | Aug 4, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-003255 | Jul 17, 2025 | — |
| 8-K | 8-K | 0000950170-25-093456 | Jul 3, 2025 | Jul 1, 2025 |
| SCHEDULE 13G | — | 0001104659-25-064765 | Jul 1, 2025 | — |
| 8-K | 8-K | 0000950170-25-087907 | Jun 18, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-071996 | May 15, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-071992 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-045055 | May 6, 2025 | — |
| DEFA14A | DEFA14A | 0000950170-25-059575 | Apr 29, 2025 | — |
| DEF 14A | DEF 14A | 0000950170-25-059573 | Apr 29, 2025 | — |
| 144 | — | 0001959173-25-002656 | Apr 21, 2025 | — |
| 144 | — | 0001959173-25-002643 | Apr 17, 2025 | — |
| 144 | — | 0001959173-25-002600 | Apr 14, 2025 | — |
| SCHEDULE 13D/A | — | 0000950170-25-049860 | Apr 2, 2025 | — |
| 4 | 4 | 0000950170-25-048905 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | 4 | 0000950170-25-048903 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | 4 | 0000950170-25-048902 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | 4 | 0000950170-25-048901 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | 4 | 0000950170-25-048900 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | 4 | 0000950170-25-048899 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | 4 | 0000950170-25-048898 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | 4 | 0000950170-25-048895 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | 4 | 0000950170-25-048894 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | 4 | 0000950170-25-048893 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | 4 | 0000950170-25-048892 | Apr 2, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-043491 | Mar 24, 2025 | — |